Navigation Links
Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results
Date:2/27/2009

(R): For the quarter ended December 31, 2008, net sales of LIDODERM decreased 2% to $205.4 million compared with $208.7 million in the same period a year ago. Prescription volume for LIDODERM increased 1% in the fourth quarter of 2008 versus the comparable 2007 period. For the year ended December 31, 2008, net sales of LIDODERM increased 8% to $765.1 million compared with $705.6 million in the same period a year ago. Prescription volume for LIDODERM increased 6% in the twelve months of 2008 versus the comparable 2007 period.

OPANA(R) ER and OPANA(R): Combined net sales for the OPANA franchise increased 81% to $52.3 million for the fourth quarter 2008 compared with $28.9 million in the same period a year ago. Prescription volume for OPANA ER and OPANA increased 64% in the fourth quarter 2008 versus the comparable 2007 period. For the year ended December 31, 2008, net sales for the OPANA franchise increased 68% to $180.4 million compared with $107.1 million in the same period a year ago. The 2007 annual results include the recognition of $13.8 million in deferred revenue for commercial shipments of OPANA ER and OPANA made to customers in 2006.

PERCOCET(R): Net sales of PERCOCET were $33.4 million for the three months ended December 31, 2008 compared with $30.6 million in the same period in 2007. Net sales of PERCOCET were $130.0 million for the year ended December 31, 2008 compared with $121.7 million in the same period in 2007.

FROVA(R): Net sales of FROVA were $16.8 million for the three months ended December 31, 2008 compared with $14.1 million for the same period in 2007. Prescription volume increased 9% for the twelve months of 2008 versus the comparable 2007 period. For the year ended December 31, 2008, net sales of FROVA were $58.0 million compared with $52.4 million in the same period in 2007.

VOLTA
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
2. Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights
3. Arbor Pharmaceuticals Announces the Launch of XYLAREX(TM) - A New Nonantibiotic Product for the Dietary Management of Recurrent Ear Infections in Children
4. Endo Pharmaceuticals Appoints William Montague to Board of Directors
5. Access Pharmaceuticals Closes Acquisition of MacroChem Corp.
6. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
7. Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
8. Transdel Pharmaceuticals, Inc. Featured on National Broadcast Television
9. Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
10. Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP
11. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... its top dressmaking technologies, has been a leading dress supplier ... latest designs of wedding dresses and launching a site-wide promotion ... the fresh new products are designed for 2015, and they ... All the clothes from LunaDress follow up with the latest ...
(Date:1/22/2015)... Glendale, AZ (PRWEB) January 22, 2015 Padre ... a long supporter of Pro Player Health Alliance ... with Padre Murphy's in getting everyone, including NFL greats, treated ... one of the leading groups supporting the cause in the ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota ... it means to “Live Fearless.” , The “Faces ... their stories about how they or someone they know has ... living in the moment. By telling these types of stories ...
(Date:1/22/2015)... Dallas, TX (PRWEB) January 22, 2015 ... the issue of experience and person-centeredness in the long-term ... moving towards action across the continuum. The paper, “The ... the Continuum,” engages perspectives and practices of the patient, ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the basic ... , Purchasing an accidental death and dismemberment rider for a ... rider provides benefits if the insured dies in an accident. ... of life insurance. , AD&D is not expensive and ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... The American people,through the United States ... of four partners, will assist in building ... prevention, malaria and child,survival programs. The Behavior ... district stakeholders, the private sector and Government ...
... The incidence of,type 2 diabetes is rising, especially ... and obesity abound. In addition to weight and,inactivity, ... developing type 2,diabetes. The incidence of diabetes is ... prevalence. An estimated 32 million Asian,Indians have been ...
... KANSAS CITY, Mo., Feb. 29 Hostess(R) 100 ... New Product Launch (MMNPL) of 2007 in,a survey ... Resources, Inc. (IRI). Hostess 100 Calorie Pack Cup ... portion-,controlled, snack sized packages each containing three scrumptious ...
... of the Indian spice turmeric for psoriasis received a ... a leading dermatology journal stating that the low response ... the exotic spice was probably a result of the ... of Medicine found that despite strong scientific evidence in ...
... 29 Richard P. Miller,of Marlton, president and CEO ... of the board of the New Jersey Hospital Association,(NJHA,) ... as the appointment of new board members, was held,during ... "As we look to the future of New ...
... Health Corp. (Nasdaq:,WBMD) and HLTH Corporation (Nasdaq: HLTH ... participate at the Morgan Stanley Technology,Conference on Tuesday, March ... and the general public are invited to listen to ... The broadcast,can be accessed at http://www.wbmd.com (in ...
Cached Medicine News:Health News:USAID Implements Behavior Change and Social Marketing Program in Rwanda 2Health News:Mayo Researchers Look for Explanation Behind High Incidence of Diabetes Among Asian Indians 2Health News:Mayo Researchers Look for Explanation Behind High Incidence of Diabetes Among Asian Indians 3Health News:Hostess(R) 100 Calorie Pack Cup Cakes Named A Most Memorable New Product of 2007 2Health News:Popular alternative therapy for psoriasis performs no better than placebo 2Health News:New Jersey Hospital Association Names New Chairman, Appoints Board Officers and New Members 2
(Date:1/23/2015)... YORK , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ... board of directors of Advaxis, Inc. ("Advaxis" or the ... board has breached its fiduciary duties to shareholders. ... on an investing website reporting that Advaxis had misrepresented ...
(Date:1/23/2015)... Idaho , Jan. 23, 2015  Now available for ... No. 7,849,611) support that prevents ankle sprains by cushioning ... brace, it fits securely around the outside of any ... mobility & comfort while still offering protection against sprains. ...
(Date:1/23/2015)... , Jan. 23, 2015 Cord Blood America, Inc. ... ("CBAI" or the "Company")  filed a Preliminary Proxy Statement, Schedule ... ) today, and provides an update for shareholders detailing why ... is requested. Dear Shareholders, As we ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... Approval of New Anti-TNF Therapy in Three Rheumatic Diseases ... and KENILWORTH, N.J., June 26 Centocor Ortho Biotech ... announced today that the Committee for Medicinal Products for ... adopted a positive opinion recommending the approval of SIMPONI(TM) ...
... As of mid-2009, The Michael J. Fox Foundation for ... high-risk, high-reward approaches to Parkinson,s therapeutic development through its ... investigations of the safety and efficacy of an FDA-approved ... a tenuous link between PD and certain strains of ...
Cached Medicine Technology:SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 2MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 3
... personal-sized Thermal Cycler is the ideal instrument for ... range of PCR applications. Get Applied ... Save lab space without sacrificing results. ... Industry-Standard PCR Technology You Can Afford ...
... ep Extremely fast heating and cooling ... Intuitive graphic programming Can be used ... or a PC-controlled network Heated lid with ... motorized lid for integration into fully automated ...
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
PxE thermal Cycler. 0.5ml block holds 48 0.5 ml tubes or 96 0.3 ml tubes. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User frien...
Medicine Products: